XKRX:005500 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
18000.00
(-0.33%)
Nov 8
Business Description
Samjin Pharmaceutical Co Ltd
ISIN : KR7005500004
Share Class Description:
XKRX:005500: Ordinary SharesCompare
Compare
Traded in other countries / regions
005500.Korea IPO Date
1988-06-18Description
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | 2.67 | |||||
| Interest Coverage | 5.2 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.71 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | -4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -12.2 | |||||
| 3-Year FCF Growth Rate | -20.4 | |||||
| 3-Year Book Growth Rate | 6.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.69 | |||||
| 9-Day RSI | 35.47 | |||||
| 14-Day RSI | 38.7 | |||||
| 6-1 Month Momentum % | -6.03 | |||||
| 12-1 Month Momentum % | -16.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 171.87 | |||||
| Days Sales Outstanding | 71.24 | |||||
| Days Payable | 33.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.44 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| Forward Dividend Yield % | 4.44 | |||||
| 5-Year Yield-on-Cost % | 4.43 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -2.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.71 | |||||
| Operating Margin % | 8.84 | |||||
| Net Margin % | 13.14 | |||||
| FCF Margin % | 7.1 | |||||
| ROE % | 14.39 | |||||
| ROA % | 9.05 | |||||
| ROIC % | 5.88 | |||||
| 3-Year ROIIC % | -1.39 | |||||
| ROC (Joel Greenblatt) % | 8.47 | |||||
| ROCE % | 9.11 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.97 | |||||
| Forward PE Ratio | 11.38 | |||||
| PE Ratio without NRI | 5.89 | |||||
| Price-to-Owner-Earnings | 16.93 | |||||
| PS Ratio | 0.78 | |||||
| PB Ratio | 0.81 | |||||
| Price-to-Tangible-Book | 0.88 | |||||
| Price-to-Free-Cash-Flow | 11.04 | |||||
| Price-to-Operating-Cash-Flow | 5.09 | |||||
| EV-to-EBIT | 13.14 | |||||
| EV-to-EBITDA | 7.76 | |||||
| EV-to-Revenue | 1.13 | |||||
| EV-to-FCF | 15.97 | |||||
| Price-to-Projected-FCF | 1.42 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Graham-Number | 0.48 | |||||
| Earnings Yield (Greenblatt) % | 7.62 | |||||
| FCF Yield % | 9.21 | |||||
| Forward Rate of Return (Yacktman) % | -11.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Samjin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 292,331.634 | ||
| EPS (TTM) (â‚©) | 3010 | ||
| Beta | 0.15 | ||
| Volatility % | 10.48 | ||
| 14-Day RSI | 38.7 | ||
| 14-Day ATR (â‚©) | 283.837341 | ||
| 20-Day SMA (â‚©) | 18417 | ||
| 12-1 Month Momentum % | -16.7 | ||
| 52-Week Range (â‚©) | 17110 - 23350 | ||
| Shares Outstanding (Mil) | 12.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Samjin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Samjin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Samjin Pharmaceutical Co Ltd Frequently Asked Questions
What is Samjin Pharmaceutical Co Ltd(XKRX:005500)'s stock price today?
The current price of XKRX:005500 is â‚©18000.00. The 52 week high of XKRX:005500 is â‚©23350.00 and 52 week low is â‚©17110.00.
When is next earnings date of Samjin Pharmaceutical Co Ltd(XKRX:005500)?
The next earnings date of Samjin Pharmaceutical Co Ltd(XKRX:005500) is .
Does Samjin Pharmaceutical Co Ltd(XKRX:005500) pay dividends? If so, how much?
The Dividend Yield %  of Samjin Pharmaceutical Co Ltd(XKRX:005500) is 4.44% (As of Today), Highest Dividend Payout Ratio of Samjin Pharmaceutical Co Ltd(XKRX:005500) was 0.81. The lowest was 0.26. And the median was 0.35. The  Forward Dividend Yield % of Samjin Pharmaceutical Co Ltd(XKRX:005500) is 4.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers